[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100399188":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":108,"collaborators":110,"id":117,"slug":118,"hasResults":119,"nctId":120,"briefTitle":121,"officialTitle":122,"acronym":123,"eligibilityCriteria":124,"healthyVolunteers":125,"sex":126,"minAge":127,"maxAge":128,"enrollmentInfo":129,"targetDuration":10,"studyType":132,"phases":10,"briefSummary":133,"conditions":134,"keywords":137,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":149,"lastUpdatePostDateStruct":150,"startDateStruct":153,"completionDateStruct":155,"leadSponsor":157,"locationsCount":158},{"fullName":5,"class":6},"Sanford Health","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Study Group",null,"Children receiving routine care at a Sanford facility",[13,14],"Diagnostic Test: Sera and whole blood sampling","Diagnostic Test: Differential Gene Expression (DGE)",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"DIAGNOSTIC_TEST","Sera and whole blood sampling","* Study Entry: Single Nucleotide Polymorphism (SNP)-Based Genetic Risk Score at study entry.\n* 2 years old: T1D autoantibodies, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibodies\n* 5 years old: T1D and celiac autoantibodies\n* 9-16 year old: one-time T1D and celiac autoantibodies\n* Siblings of people with T1D autoimmunity, ages 6-17 years: one-time T1D and celiac autoantibodies",[9],{"type":17,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"Differential Gene Expression (DGE)","Opt-in: Differential Gene Expression from cord blood at birth and peripheral blood at 12 months of age",[9],[26],{"name":27,"affiliation":28,"role":29},"Kurt Griffin, PhD, MD","Sanford Research","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":10,"email":35},"Ann Mays, RN, CPN","CONTACT","605-312-6052","ann.mays@sanfordhealth.org",[37,54,67,80],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Sanford Bemidji Region Clinics","RECRUITING","Bemidji","Minnesota","56601","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-94.88028,47.47356,{"lat":49,"lon":48},[52,53],{"name":32,"role":33,"phone":34,"phoneExt":10,"email":35},{"name":27,"role":29,"phone":10,"phoneExt":10,"email":10},{"facility":55,"status":39,"city":56,"state":57,"zip":58,"country":43,"countryCode":44,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"Sanford Bismarck Region Clinics","Bismarck","North Dakota","58501",{"type":46,"coordinates":60},[61,62],-100.78374,46.80833,{"lat":62,"lon":61},[65,66],{"name":32,"role":33,"phone":34,"phoneExt":10,"email":35},{"name":27,"role":29,"phone":10,"phoneExt":10,"email":10},{"facility":68,"status":39,"city":69,"state":57,"zip":70,"country":43,"countryCode":44,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"Sanford Fargo Region Clinics","Fargo","58112",{"type":46,"coordinates":72},[73,74],-96.7898,46.87719,{"lat":74,"lon":73},[77,79],{"name":78,"role":33,"phone":34,"phoneExt":10,"email":35},"Ann Mays",{"name":27,"role":29,"phone":10,"phoneExt":10,"email":10},{"facility":81,"status":39,"city":82,"state":83,"zip":84,"country":43,"countryCode":44,"cosmosGeoPoint":85,"geoPoint":89,"contacts":90},"Sanford Sioux Falls Region Clinics","Sioux Falls","South Dakota","57105",{"type":46,"coordinates":86},[87,88],-96.72796,43.54369,{"lat":88,"lon":87},[91,93,94,97,99,101,103,105,107],{"name":78,"role":33,"phone":92,"phoneExt":10,"email":35},"6053126052",{"name":27,"role":29,"phone":10,"phoneExt":10,"email":10},{"name":95,"role":96,"phone":10,"phoneExt":10,"email":10},"Sharon Hunt, BS, MS, MBA","SUB_INVESTIGATOR",{"name":98,"role":96,"phone":10,"phoneExt":10,"email":10},"Candice Nelson, MD, FAAP",{"name":100,"role":96,"phone":10,"phoneExt":10,"email":10},"Stephanie Hanson, MD, FAAP",{"name":102,"role":96,"phone":10,"phoneExt":10,"email":10},"Louis Casas, MD, FAAP",{"name":104,"role":96,"phone":10,"phoneExt":10,"email":10},"Brenda Thurlow, MD, FAAP",{"name":106,"role":96,"phone":10,"phoneExt":10,"email":10},"Kyle Baum, MD",{"name":32,"role":96,"phone":10,"phoneExt":10,"email":10},{"type":109,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[111,113,115],{"name":112,"class":6},"The Leona M. and Harry B. Helmsley Charitable Trust",{"name":114,"class":6},"Pacific Northwest Research Institute",{"name":116,"class":6},"University of Exeter","100399188","general-population-level-estimation-for-type-1-diabetes-risk-in-children-during-routine-care-delivery-100399188",false,"NCT04477928","General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery","Sanford Population Level Estimation of Type 1 Diabetes Risk GEnes in Children","PLEDGE","Inclusion Criteria:\n\n* Newborn Entry: Viable, term infants, defined as 36 weeks gestation by either dates or ultrasound who are born to pregnant women, 18 years or older, who are willing and able to provide informed consent (IC) prior to the onset of active labor. Who are born at a Sanford Health Hospital and plan to have routine well-child care at a Sanford Clinic\n* Pediatric Entry: Children less than 6 years of age who receive their routine care at a Sanford facility and whose parents are able to provide IC.\n* Adolescent Entry: Children, ages 9-16 years old, who receive their routine care at a Sanford facility and whose parents are able to provide IC.\n* Siblings of children known to have T1D-relevant antibodies; ages 6 to 17 years old who receive care at a Sanford clinic\n* Have an active MyChart account (with proxy access).\n\nExclusion Criteria:\n\n* Subject is in the opinion of the investigator, unable to comply with the requirements of the study protocol.\n* Children known to have T1D",true,"ALL","0 Minutes","17 Years",{"count":130,"type":131},33000,"ESTIMATED","OBSERVATIONAL","In partnership with Helmsley Charitable Trust, the Sanford PLEDGE Study is a large-scale, observational, feasibility study of general population screening for T1D and celiac autoantibodies. Screening is incorporated into routine health care visits within an integrated health system.",[135,136],"Type 1 Diabetes","Celiac Disease",[138,135,136,139,140,141,142,143,144,145,146,147,148],"Population screening","Autoantibodies","Prevention","Diabetic Ketoacidosis (DKA)","Genetic Risk Score","Differential Gene Expression","Economic Modeling","Quality of Life","Feasibility","Pragmatic","T1D","2026-02-26",{"date":151,"type":152},"2026-03-02","ACTUAL",{"date":154,"type":152},"2020-07-17",{"date":156,"type":131},"2031-03",{"name":5,"class":6},4]